DK155525C - Fremgangsmaade til fremstilling af (6r,7r)-7-oe(z)-2-(2-aminotiazol-4-yl)-2-(2-karboxyprop-2-oxyimino)-acetamidoaa-3-(1-pyridiniummetyl)-ceph-3-em-4-karboxylat-pentahydrat - Google Patents

Fremgangsmaade til fremstilling af (6r,7r)-7-oe(z)-2-(2-aminotiazol-4-yl)-2-(2-karboxyprop-2-oxyimino)-acetamidoaa-3-(1-pyridiniummetyl)-ceph-3-em-4-karboxylat-pentahydrat

Info

Publication number
DK155525C
DK155525C DK414780A DK414780A DK155525C DK 155525 C DK155525 C DK 155525C DK 414780 A DK414780 A DK 414780A DK 414780 A DK414780 A DK 414780A DK 155525 C DK155525 C DK 155525C
Authority
DK
Denmark
Prior art keywords
acetamidoaa
aminotiazol
carboxyprop
ceph
oxyimino
Prior art date
Application number
DK414780A
Other languages
Danish (da)
English (en)
Other versions
DK414780A (da
DK155525B (da
Inventor
Alastair Couper Brodie
Lewis Aubrey Wetherill
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of DK414780A publication Critical patent/DK414780A/da
Publication of DK155525B publication Critical patent/DK155525B/da
Application granted granted Critical
Publication of DK155525C publication Critical patent/DK155525C/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/38—Methylene radicals, substituted by nitrogen atoms; Lactams thereof with the 2-carboxyl group; Methylene radicals substituted by nitrogen-containing hetero rings attached by the ring nitrogen atom; Quaternary compounds thereof
    • C07D501/46—Methylene radicals, substituted by nitrogen atoms; Lactams thereof with the 2-carboxyl group; Methylene radicals substituted by nitrogen-containing hetero rings attached by the ring nitrogen atom; Quaternary compounds thereof with the 7-amino radical acylated by carboxylic acids containing hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK414780A 1979-10-02 1980-10-01 Fremgangsmaade til fremstilling af (6r,7r)-7-oe(z)-2-(2-aminotiazol-4-yl)-2-(2-karboxyprop-2-oxyimino)-acetamidoaa-3-(1-pyridiniummetyl)-ceph-3-em-4-karboxylat-pentahydrat DK155525C (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB7934204 1979-10-02
GB7934204 1979-10-02

Publications (3)

Publication Number Publication Date
DK414780A DK414780A (da) 1981-04-03
DK155525B DK155525B (da) 1989-04-17
DK155525C true DK155525C (da) 1989-09-04

Family

ID=10508246

Family Applications (1)

Application Number Title Priority Date Filing Date
DK414780A DK155525C (da) 1979-10-02 1980-10-01 Fremgangsmaade til fremstilling af (6r,7r)-7-oe(z)-2-(2-aminotiazol-4-yl)-2-(2-karboxyprop-2-oxyimino)-acetamidoaa-3-(1-pyridiniummetyl)-ceph-3-em-4-karboxylat-pentahydrat

Country Status (36)

Country Link
US (1) US4329453A (de)
JP (1) JPS5657791A (de)
KR (1) KR840001776B1 (de)
AT (1) AT368161B (de)
AU (1) AU539519B2 (de)
BE (1) BE885489A (de)
BG (1) BG33586A3 (de)
CA (1) CA1142919A (de)
CH (1) CH645118A5 (de)
CS (1) CS214721B2 (de)
CY (1) CY1338A (de)
DD (1) DD153376A5 (de)
DE (1) DE3037102C2 (de)
DK (1) DK155525C (de)
EC (1) ECSP941099A (de)
ES (1) ES495534A0 (de)
FI (1) FI71157C (de)
FR (1) FR2466467A1 (de)
GB (1) GB2063871B (de)
GR (1) GR69123B (de)
HK (1) HK78686A (de)
HU (1) HU184835B (de)
IT (1) IT1144006B (de)
KE (1) KE3641A (de)
MX (1) MX6545E (de)
MY (1) MY8500315A (de)
NL (1) NL190329C (de)
NO (1) NO156246C (de)
PL (1) PL126606B1 (de)
PT (1) PT71860B (de)
RO (1) RO82721B (de)
SE (1) SE449614B (de)
SU (1) SU942599A3 (de)
UA (1) UA7208A1 (de)
YU (1) YU42357B (de)
ZA (1) ZA806081B (de)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4443444A (en) * 1980-08-11 1984-04-17 Fujisawa Pharmaceutical Co., Ltd. Cephem compounds
US4427677A (en) 1980-12-31 1984-01-24 Fujisawa Pharmaceutical Co., Ltd. Cephem compounds
US4394503A (en) 1981-12-07 1983-07-19 Bristol-Myers Company Cephalosporin derivatives
US4474954A (en) * 1981-12-07 1984-10-02 Bristol-Myers Company Intermediates for cephalosporin derivatives
JPS58198489A (ja) * 1982-05-14 1983-11-18 Meiji Seika Kaisha Ltd ７β−（２Ｄ−２−アミノ−２−カルボキシエチルチオアセトアミド）−７α−メトキシ−３−（１−メチル−１Ｈ−テトラゾ−ル−５−イル）−チオメチル−３−セフエム−４−カルボン酸ナトリウム塩の七水和物及びその製造方法
ES525492A0 (es) * 1982-09-10 1985-02-01 Glaxo Group Ltd Un procedimiento para la produccion de un recipiente hermeticamente cerrado que contiene al menos un antibiotico de beta-lactama.
DE3313818A1 (de) * 1983-04-16 1984-10-18 Hoechst Ag, 6230 Frankfurt Neue kristallmodifikation von ceftazidim
DE3313816A1 (de) * 1983-04-16 1984-10-18 Hoechst Ag, 6230 Frankfurt Neue kristallmodifikation von ceftazidim
GB8406218D0 (en) * 1984-03-09 1984-04-11 Glaxo Group Ltd Process
US4537959A (en) * 1984-03-26 1985-08-27 Eli Lilly And Company Crystalline cephalosporin antibiotic salt
JPS60231683A (ja) * 1984-05-02 1985-11-18 Teijin Ltd セフアロスポリン誘導体その製造法及びそれを有効成分とする抗菌剤
US4616080A (en) * 1984-07-02 1986-10-07 Eli Lilly And Company Simplified process of forming crystalline ceftazidime pentahydrate
US4626534A (en) * 1984-07-23 1986-12-02 Eli Lilly And Company Pharmaceutical formulation
EP0169700B1 (de) * 1984-07-23 1990-05-16 Eli Lilly And Company Pharmazeutische Zusammensetzungen von Ceftazidim
US4659813A (en) * 1984-11-08 1987-04-21 Eli Lilly And Company Crystallization process for ceftazidime derivative
CA1239389A (en) * 1984-11-08 1988-07-19 Melvin G. Pleiss, Jr. Crystallization process
US5244891A (en) * 1985-08-05 1993-09-14 Bristol-Myers Squibb Company Injectable compositions of cefepime dihydrochloride hydrate
US4910301A (en) * 1985-08-05 1990-03-20 Bristol-Myers Company Cefepime cephalosporin salts
US4994451A (en) * 1988-01-19 1991-02-19 Bristol-Myers Company Cephalosporin salts and injectable compositions
US4954624A (en) * 1986-10-07 1990-09-04 Sandoz Ltd. Process for the production of cephalosporin derivatives
AT387390B (de) * 1986-10-07 1989-01-10 Biochemie Gmbh Verfahren zur herstellung des antibiotikums (6r,7r)-7-(2-(2-amino-4-thiazolyl)-2-(2-carboxy
EP0278656B1 (de) * 1987-02-02 1992-06-03 Eli Lilly And Company Verfahren zur Herstellung von Ceftazidime-Pentahydrat
US5021564A (en) * 1987-02-02 1991-06-04 Eli Lilly And Company Process for preparing ceftazidime pentahydrate
WO1988010262A1 (fr) * 1987-06-25 1988-12-29 Banyu Pharmaceutical Co., Ltd. Compose cristallin de cephalosporine
EP0321562B1 (de) * 1987-06-25 1993-11-24 Banyu Pharmaceutical Co., Ltd. Kristalline cephalosporinzusammensetzungen, verfahren und zwischenprodukte für ihre herstellung
GB8802622D0 (en) * 1988-02-05 1988-03-02 Glaxo Group Ltd Chemical compound
KR940000112B1 (ko) * 1990-07-05 1994-01-05 주식회사 대웅제약 신규의 3-치환 세펨화합물 및 그의 제조방법
US5831085A (en) * 1997-01-16 1998-11-03 Lupin Laboratories Limited Process for manufacture of cephalosporin such as ceftazidime and intermediate thereof
CN1328281C (zh) * 2004-11-16 2007-07-25 广州白云山制药股份有限公司 头孢他啶的纯化方法
CN102875576A (zh) * 2012-10-31 2013-01-16 苏州致君万庆药业有限公司 一种抗菌素头孢他啶的合成、注射用头孢他啶及其制备方法
CN102924483B (zh) * 2012-10-31 2015-06-17 海南合瑞制药股份有限公司 一种头孢他啶晶体化合物、其制备方法及其无菌混合粉形式的药物组合物
CN104876949A (zh) * 2015-05-28 2015-09-02 浙江长典医药有限公司 一种小儿用头孢他啶化合物实体及其制剂
CN106420658A (zh) * 2016-09-23 2017-02-22 临沂草之美医药科技有限公司 一种治疗外科手术感染的药物头孢他啶胶囊
CN109111467A (zh) * 2017-06-22 2019-01-01 宁应 一种51/4水头孢他啶化合物及其药物组合物制剂

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR228726A1 (es) * 1978-05-26 1983-04-15 Glaxo Group Ltd Procedimiento para la preparacion del antibiotico(6r,7r)-7-((z)-2-(2-aminotiazol-4-il)-2-(2-carboxiprop-2-oxiimino)acetamido)-3-(1-piridiniometil)cef-3-em-4-carboxilato

Also Published As

Publication number Publication date
DE3037102A1 (de) 1981-04-23
GB2063871A (en) 1981-06-10
NL190329C (nl) 1994-01-17
FI71157C (fi) 1986-11-24
ES8106908A1 (es) 1981-09-01
KR830004317A (ko) 1983-07-09
GR69123B (de) 1982-05-03
FI71157B (fi) 1986-08-14
FR2466467B1 (de) 1984-02-10
IT8049783A0 (it) 1980-10-01
JPS5657791A (en) 1981-05-20
YU249780A (en) 1983-02-28
MY8500315A (en) 1985-12-31
KE3641A (en) 1986-07-11
NL190329B (nl) 1993-08-16
SE449614B (sv) 1987-05-11
DD153376A5 (de) 1982-01-06
BG33586A3 (en) 1983-03-15
RO82721B (ro) 1984-10-30
GB2063871B (en) 1983-06-02
FI803126L (fi) 1981-04-03
AU539519B2 (en) 1984-10-04
PL227019A1 (de) 1981-06-05
DK414780A (da) 1981-04-03
HK78686A (en) 1986-10-24
NO156246B (no) 1987-05-11
JPH0128036B2 (de) 1989-05-31
IT1144006B (it) 1986-10-29
DK155525B (da) 1989-04-17
ZA806081B (en) 1982-05-26
ATA490080A (de) 1982-01-15
DE3037102C2 (de) 1986-04-10
ECSP941099A (es) 1995-01-16
FR2466467A1 (fr) 1981-04-10
MX6545E (es) 1985-07-10
AU6288280A (en) 1981-04-09
NL8005443A (nl) 1981-04-06
CY1338A (en) 1987-01-16
CS214721B2 (en) 1982-05-28
ES495534A0 (es) 1981-09-01
KR840001776B1 (ko) 1984-10-19
SE8006861L (sv) 1981-04-03
HU184835B (en) 1984-10-29
RO82721A (ro) 1984-09-29
PT71860A (en) 1980-11-01
UA7208A1 (uk) 1995-06-30
NO802913L (no) 1981-04-03
BE885489A (fr) 1981-04-01
SU942599A3 (ru) 1982-07-07
CA1142919A (en) 1983-03-15
YU42357B (en) 1988-08-31
US4329453A (en) 1982-05-11
PT71860B (en) 1982-04-02
PL126606B1 (en) 1983-08-31
CH645118A5 (de) 1984-09-14
NO156246C (no) 1987-08-19
AT368161B (de) 1982-09-27

Similar Documents

Publication Publication Date Title
DK155525C (da) Fremgangsmaade til fremstilling af (6r,7r)-7-oe(z)-2-(2-aminotiazol-4-yl)-2-(2-karboxyprop-2-oxyimino)-acetamidoaa-3-(1-pyridiniummetyl)-ceph-3-em-4-karboxylat-pentahydrat
DK540080A (da) Fremgangsmaade til fremstilling af 2-amino-4-hydroxyquinazolinderivater
DK157685C (da) Analogifremgangsmaade til fremstilling af (6r,7r)-7-oe(z)-2-(2-aminotiazol)-4-yl)-2-(2-karboxyprop-2-oxyimino)-acetamidoaa-3-(1-pyridiniummetyl)-ceph-3-em-4-karboxylat eller ugiftige salte eller ugiftige metabolisk labile estere deraf
DK42480A (da) Fremgangsmaade til fremstilling af 1-aryl-2-acylamido-3-fluor-1-propanoler
MX157171A (es) Procedimiento para preparar compuestos 1-oxa,aza-y tia-espirociclos
DK491780A (da) Fremgangsmaade til fremstilling af cephalosporansyrederivater
DK75077A (da) Fremgangsmade til fremstilling af cephemforbindelser
ES514796A0 (es) Procedimiento para preparar compuestos tetrakisazoicos.
DK143491D0 (da) Fremgangsmaade til fremstilling af 3-oen-phenylacetylaminopiperidinaa-2,6-dion
DK502078A (da) Frefmgangsmaade til fremstilling af cephalosporansyrederivater
IT8024382A0 (it) Metodo per la preparazione dicomposti fluorocarbonilici.
DK158669C (da) Fremgangsmaade til fremstilling af 6beta-halogensubstituerede penicillansyrederivater.
ES519006A0 (es) Procedimiento para preparar 2-(2-dimetilaminoetiltio)-3-fenilquinolina.
DK447380A (da) Fremgangsmaade til fremstilling af d3-vitaminforbindelser
DK99980A (da) Fremgangsmaade til fremstilling af mercaptoacyldihydropyrazolcarboxylsyrederivater
NL7800744A (nl) Nieuwe imidazochinolinen en hun zouten, werk- wijze ter bereiding van deze verbindingen en farmaceutische samenstellingen.
ES509044A0 (es) Procedimiento para preparar derivados de fenilsulfonilurea sustituidos.
ES517333A0 (es) Procedimientos para preparar derivados piridazinona.
ES506842A0 (es) Procedimiento para preparar derivados 3-aminopropoxifenili- cos.
AR228869A1 (es) Procedimiento para preparar nuevos compuestos cefalosporanicos
ES517824A0 (es) Procedimiento para preparar derivados de cefalosporina.
DK135480A (da) Fremgangsmaade til fremstilling af 2-(2-pyridyl)-tetrahydrothiopen-derivater
DK159449C (da) Fremgangsmaade til fremstilling af natrium-cefuroxim
DK454579A (da) Fremgangsmaade til fremstilling af 6-piperidino-2,4-diaminopyrimidin-3-oxid
DK188881A (da) Fremgangsmaade til fremstilling af 2-guanidinthiazol-derivater

Legal Events

Date Code Title Description
PUP Patent expired